Explore Pfizer College Alumni


 Which college alumni are working at Pfizer?

Pfizer Inc. / ˈ f aɪ z ər / is an American pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut.

Recent News for Pfizer

Pfizer : Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG and BOSULIF about 3 hours ago
NEW YORK, Feb. 23-- Pfizer, a pharmaceutical company, issued the following news release: Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive ...
Pfizer : Albert Bourla Elected to Pfizer's Board of Directors about 4 hours ago
NEW YORK, Feb. 23-- Pfizer, a pharmaceutical company, issued the following news release: Pfizer Inc. today announced the election of Albert Bourla, DVM, Ph.D. to its Board of Directors, effective immediately.
Bristol losing its I/O talent to the likes of Pfizer, report finds about 12 hours ago
Bristol-Myers Squibb Co.'s prowess in immuno-oncology has made its workforce in that field an attractive target for rivals like Pfizer Inc. and Celgene Corp., according to a new report. "BMS has successfully branded itself a leader in I-O R&D," hiQ Labs ...
Who’s next? These 5 buildings may take advantage of the Midtown East rezoning about 21 hours ago
Shortly after the City Council signed off on the Midtown East rezoning, Pfizer announced that it planned to sell its headquarters and move to Tishman Speyer’s Hudson Yards office tower, the Spiral. Negotiations appear to be ongoing, and it’s not clear ...
Pfizer makes $500 million contribution to U.S. pension plans about 22 hours ago
Pfizer Inc., New York, made a $500 million contribution to its U.S. pension plans earlier this month, and it expects to make a $226 million contribution to its international pension plans this year, the company reported in its 10-K filing Thursday.
BRIEF-Pfizer Receives Positive CHMP Opinion For Two Hematology Medicines about 1 day ago
* PFIZER INC - CHMP OF EMA HAS ADOPTED POSITIVE OPINIONS RECOMMENDING THAT MYLOTARG, BOSULIF BE GRANTED MARKETING AUTHORIZATIONS IN EU Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles.
Pfizer Gets Positive CHMP Opinion For Mylotarg And Bosulif - Quick Facts about 1 day ago
Pfizer Inc. (PFE) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency (EMA) has adopted positive opinions recommending that two of the company's hematology medicines be granted marketing authorizations in ...
Albert Bourla Elected to Pfizer’s Board of Directors about 1 day ago
Pfizer Inc. today announced the election of Albert Bourla, DVM, Ph.D. to its Board of Directors, effective immediately. Dr. Bourla, age 56, is currently the Chief Operating Officer (COO) of Pfizer. Prior to assuming the role of COO in 2018, he was the ...
Pfizer Updates On EMA Application For SUTENT about 1 day ago
Pfizer Inc. (PFE) announced that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has recommended against expanding use of SUTENT or sunitinib to include the adjuvant treatment of adult patients at a high ...
Stocks Movement Analysis: Microsoft Corporation (MSFT), Pfizer Inc. (PFE) about 1 day ago
For me, it is huge to know that I can now put down fast times in pretty much any event and contend for medals in multiple events. Lindsey Vonn and USA teammate Mikaela Shiffrin are both competing in the women's combined, their last events of the 2018 Games.